Managed Account Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Managed Account Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$25.9M	Sell	449,733 -44,389	-9%	-$2.82M	0.02%	611
2015 Q1	$31.5M	Buy	494,122 +7,843	+2%	+$532K	0.03%	541
2014 Q4	$30M	Buy	486,279 +14,690	+3%	+$725K	0.03%	538
2014 Q3	$18.3M	Buy	471,589 +86,926	+23%	+$3.08M	0.02%	722
2014 Q2	$13.3M	Sell	384,663 -180,755	-32%	-$5.69M	0.02%	882
2014 Q1	$24.4M	Buy	565,418 +164,393	+41%	+$7.97M	0.03%	587
2013 Q4	$16M	Buy	401,025 +165,991	+71%	+$5.91M	0.02%	734
2013 Q3	$8.82M	Buy	235,034 +65,755	+39%	+$1.96M	0.01%	975
2013 Q2	$4.55M	Buy	+169,279	New	+$3.6M	0.01%	1236

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Managed Account Advisors's IONS Position: Q2 2015 in Review

Managed Account Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 9% in Q2 2015, selling an estimated $2.82M and leaving 449,733 shares worth $25.9M. The position accounts for 0.02% of the portfolio, ranked #611.

Managed Account Advisors first reported a position in IONS in Q2 2013 and has held it in 9 quarters since. The position peaked at $31.5M in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

Managed Account Advisors held 449,733 shares of Ionis Pharmaceuticals worth $25.9M as of Q2 2015.
Managed Account Advisors sold 44,389 Ionis Pharmaceuticals shares in Q2 2015, an estimated $2.82M.
Ionis Pharmaceuticals made up 0.02% of Managed Account Advisors's portfolio in Q2 2015, its #611 holding.
Managed Account Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Ionis Pharmaceuticals position peaked at $31.5M in Q1 2015.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.